Susquehanna International Group, LLP Ionis Pharmaceuticals Inc Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $2.52 Million - $3.27 Million	-63,000 Reduced 51.77%	58,700 $2.35 Million
Q2 2024 Aug 15, 2024	SELL	$36.45 - $47.7 $2.54 Million - $3.32 Million	-69,700 Reduced 36.42%	121,700 $5.8 Million
Q1 2024 May 07, 2024	BUY	$42.03 - $53.55 $1.46 Million - $1.86 Million	34,700 Added 22.14%	191,400 $8.3 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $1.76 Million - $2.09 Million	40,500 Added 34.85%	156,700 $7.93 Million
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $1.22 Million - $1.5 Million	-31,800 Reduced 21.49%	116,200 $5.27 Million
Q2 2023 Aug 11, 2023	BUY	$34.73 - $43.33 $3.73 Million - $4.65 Million	107,300 Added 263.64%	148,000 $6.07 Million
Q1 2023 May 16, 2023	SELL	$33.58 - $41.2 $856,290 - $1.05 Million	-25,500 Reduced 38.52%	40,700 $1.45 Million
Q4 2022 Feb 14, 2023	SELL	$37.12 - $46.52 $579,072 - $725,712	-15,600 Reduced 19.07%	66,200 $2.5 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $401,940 - $535,260	-11,000 Reduced 11.85%	81,800 $3.62 Million

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.